Home > Newsletters > FDAnews Drug Daily Bulletin > Industry Groups Promote Supply Chain ‘Mapping’ to Prioritize Risks
FDAnews Drug Daily Bulletin
June 22, 2012 | Vol. 9 No. 123
Industry Groups Promote Supply Chain ‘Mapping’ to Prioritize Risks
Drugmakers can help secure the global supply chain from counterfeits and cargo theft by mapping their network of suppliers to better assess their risks and prioritize mitigation, industry groups say. As a first step, drugmakers should catalogue each third-party provider and visualize the paths of product movement between facilities, the pharma industry consortium Rx360 recommends in a newly published white paper.
Washington Drug Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.